Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Maria Larsson

Researcher

Maria Larsson
Researcher
maria.larsson@radfys.gu.se


Department of Radiation Physics at Institute of Clinical Sciences (More Information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
Visiting Address: Gula stråket 2 B SU/Sahlgrenska , 413 45 Göteborg

Latest publications

Optimization of 177Lu-octreotate treatment of neuroendocrine tumours
Eva Forssell-Aronsson, Johan Spetz, Britta Langen, Johanna Dalmo, Maria Larsson et al.
3rd Swedish Cancer Research Meeting, Stockholm, Sweden, September 2-3, 2014, Conference contribution 2014
Conference contribution

Kidney toxicity in mice treated with 177Lu-octreotate
Maria Larsson, Emil Schüler, Toshima Z Parris, Nils Rudqvist, Khalil Helou et al.
25th Annual Congress on European Association of Nuclear Medicine, Milano, Italy, October 27-31, 2012 . (European Journal of Nuclear Medicine and Molecular Imaging), Conference contribution 2012
Conference contribution

Absorbed dose to the kidneys after treatment with 177Lu-octreotate
Maria Larsson, Peter Bernhardt, Eva Forssell-Aronsson
European Journal of Nuclear Medicine & Molecular Imaging, Conference paper 2011
Conference paper

Absorbed dose to the kidneys after treatment with 177Lu-octreotate
Maria Larsson, Peter Bernhardt, Eva Forssell-Aronsson
European Association of Nuclear Medicine Congress. Birmingham, Conference paper 2011
Conference paper

Dosimetric estimation of kidney dose after patient treatments with 177Lu- DOTA, Tyr3-octreotate on neuroendocrine somatostatin-Receptor-Expressing tumour
Maria Larsson
workshop: Quantitative imaging and dosimetry in Nuclear Medicine, Conference contribution 2008
Conference contribution

Showing 1 - 10 of 10

2015

2014

Optimization of 177Lu-octreotate treatment of neuroendocrine tumours
Eva Forssell-Aronsson, Johan Spetz, Britta Langen, Johanna Dalmo, Maria Larsson et al.
3rd Swedish Cancer Research Meeting, Stockholm, Sweden, September 2-3, 2014, Conference contribution 2014
Conference contribution

2012

Kidney toxicity in mice treated with 177Lu-octreotate
Maria Larsson, Emil Schüler, Toshima Z Parris, Nils Rudqvist, Khalil Helou et al.
25th Annual Congress on European Association of Nuclear Medicine, Milano, Italy, October 27-31, 2012 . (European Journal of Nuclear Medicine and Molecular Imaging), Conference contribution 2012
Conference contribution

2011

Absorbed dose to the kidneys after treatment with 177Lu-octreotate
Maria Larsson, Peter Bernhardt, Eva Forssell-Aronsson
European Journal of Nuclear Medicine & Molecular Imaging, Conference paper 2011
Conference paper

Absorbed dose to the kidneys after treatment with 177Lu-octreotate
Maria Larsson, Peter Bernhardt, Eva Forssell-Aronsson
European Association of Nuclear Medicine Congress. Birmingham, Conference paper 2011
Conference paper

2010

2008

Dosimetric estimation of kidney dose after patient treatments with 177Lu- DOTA, Tyr3-octreotate on neuroendocrine somatostatin-Receptor-Expressing tumour
Maria Larsson
workshop: Quantitative imaging and dosimetry in Nuclear Medicine, Conference contribution 2008
Conference contribution

Showing 1 - 10 of 10

Page Manager: Johan Spetz|Last update: 11/20/2013
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?